20: METABOLIC SYNDROME AND ARDS IN COVID-19.

B Conclusions: b MetS, diagnosed by the clustering of obesity, prediabetes/DM, HTN, and dyslipidemia, is associated with significantly increased mortality and ARDS in a global population of hospitalized COVID-19 patients. B Introduction/Hypothesis: b Little is known about metabolic syndrome (MetS) and ARDS in COVID-19. However, patients from non-US hospitals had significantly higher hospital mortality as compared with US hospitals (24.5% vs 15.7%, aOR 1.58 [CI 1.41-1.77]) with similar findings noted when patients were stratified by MetS (34.1% vs 21.3%, aOR 1.49 [CI 1.08-2.06]). [Extracted from the article]